Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis
{{output}}
Hyperphosphatemia is an important modifiable risk factor for death and cardiovascular events in patients on hemodialysis (HD). As nicotinamide has been shown as an inhibitor of sodium-dependent phosphate co-transport in rat renal tubule and small intestine, we... ...
